Patents by Inventor Sharon Ebner

Sharon Ebner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Perturbed membrane-binding compounds
    Patent number: 7396859
    Abstract: The present invention provides uses of compounds that bind selectively to cells undergoing perturbations and alterations of their normal membrane organization, while binding to a lesser degree to cell having membranes of normal organization. These compounds are termed perturbed-membrane-binding compounds (PMBC). The PMBC group of compounds includes new compounds and also known compounds.
    Type: Grant
    Filed: December 3, 2001
    Date of Patent: July 8, 2008
    Assignee: NST Neurosurvival Technologies, Ltd.
    Inventors: Ilan Ziv, Anat Shievan, Sharon Ebner
  • Agents for imaging and diagnostic methods using them
    Patent number: 7378079
    Abstract: The present invention provides novel compounds that bind selectively to cells undergoing perturbations and alterations of the normal organization of their plasma membrane, while binding to a lesser degree to cells having membranes of normal organization, and their uses as diagnostic probes. Said compounds and methods used therein may be useful in medical practice, for applications such as diagnosis of disease and monitoring of response to therapy.
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: May 27, 2008
    Assignee: NST Neurosurvival Technologies Ltd.
    Inventors: Ilan Ziv, Anat Shirvan, Sharon Ebner
  • Agents for imaging and diagnostic methods using them
    Publication number: 20050276750
    Abstract: The present invention provides novel compounds that bind selectively to cells undergoing perturbations and alterations of the normal organization of their plasma membrane, while binding to a lesser degree to cells having membranes of normal organization, and their uses as diagnostic probes. Said compounds and methods used therein may be useful in medical practice, for applications such as diagnosis of disease and monitoring of response to therapy.
    Type: Application
    Filed: June 3, 2003
    Publication date: December 15, 2005
    Inventors: Ilan Ziv, Anat Shirvan, Sharon Ebner
  • Method for targeting chemical compounds to cells and pharmaceutical compositions used therein
    Publication number: 20040141912
    Abstract: The present invention concerns a method for selectively targeting a medicinally-useful agent into cells in which a phospholipid scramblase (PLS) transport system is activated. The method comprises administering the agent, being a PLS-dependent transported compound (PDTC) to the cells, thereby causing selective transport of the agent into the cells. Examples of the cells are apoptotic cells, activated cells and injured cells. Also disclosed are pharmaceutical compositions for use by the method.
    Type: Application
    Filed: March 5, 2004
    Publication date: July 22, 2004
    Inventors: Ilan Ziv, Anat Shirvan, Sharon Ebner
  • Perturbed membrane-binding compounds
    Publication number: 20040082499
    Abstract: The present invention provides uses of compounds that bind selectively to cells undergoing perturbations and alterations of their normal membrane organization, while binding to a lesser degree to cell having membranes of normal organization. These compounds are termed perturbed-membrane-binding compounds (PMBC). The PMBC group of compounds includes new compounds and also known compounds.
    Type: Application
    Filed: October 31, 2003
    Publication date: April 29, 2004
    Inventors: Ilan Ziv, Anat Shievan, Sharon Ebner